Practical synthesis of 7-bromo-4-chloro-1H-indazol-3-amine: an important intermediate to Lenacapavir

limei jin,Naeem Asad,Michael Lyons,Shirley Muniz Machado Rodrigues,Justina Burns,Thomas Roper,George Laidlaw,Saeed Ahmad,B. Frank Gupton,Douglas Klumpp
DOI: https://doi.org/10.26434/chemrxiv-2024-2c6v2
2024-04-30
Abstract:7-Bromo-4-chloro-1H-indazol-3-amine is a heterocyclic fragment used in the synthesis of Lenacapavir, a potent capsid inhibitor for the treatment of HIV-1 infections. In this manuscript, we describe a new approach to synthesizing 7-bromo-4-chloro-1H-indazol-3-amine from inexpensive 2,6-dichlorobenzonitrile. This synthetic method utilizes a two-step sequence including a regioselective bromination and heterocycle formation with hydrazine to give the desired product in an overall isolated yield of 38-45%. The new protocol has been successfully demonstrated on hundred-gram scales without the need of column chromatography purifications. This new synthesis provides a potential economical route to large scale production of this heterocyclic fragment of Lenacapavir.
Chemistry
What problem does this paper attempt to address?
The main problem that this paper attempts to solve is to develop a cost - effective large - scale synthesis method for the preparation of 7 - bromo - 4 - chloro - 1H - indazol - 3 - amine, which is an important intermediate for the synthesis of the anti - HIV drug Lenacapavir. Specifically, a new synthetic route starting from the inexpensive raw material 2,6 - dichlorobenzonitrile is described in the paper. This route, through highly regioselective bromination and heterocycle - forming steps, finally obtains the target product with an overall yield of 38 - 45%. This new method not only avoids using the expensive 3 - bromo - 6 - chloro - 2 - fluorobenzonitrile as a starting material, but also has been successfully implemented on a 100 - gram scale without column chromatography purification, thus providing a potentially economical large - scale production path.